THE FUTURE OF GENETIC MEDICINE

Driven by technological and scientific advances, the landscape of genetic medicine is rapidly changing. This session will discuss the current state, future technologies and innovations, and solutions for manufacturing and regulatory bottlenecks as new genetic medicines move towards the clinic.

Moderator:
Nina Bauer, Ph.D., Chief Business Officer, SmartCella

Speakers:
Behnam Baghbaderani, Ph.D., Vice President, Global Head of Commercial and Program Management, Lonza
Lisa Deschamps, CEO, AviadoBio
Kinnari Patel, Pharm.D., President and Chief Operating Officer, Rocket Pharma
David Venables, Ph.D., CEO, Laverock Therapeutics
Richard Wilson, Senior Vice President, Primary Focus Lead, Genetic Regulation, Astellas Pharma